325 related articles for article (PubMed ID: 17557435)
1. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
Walsh JK; Perlis M; Rosenthal M; Krystal A; Jiang J; Roth T
J Clin Sleep Med; 2006 Jan; 2(1):35-41. PubMed ID: 17557435
[TBL] [Abstract][Full Text] [Related]
2. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
[TBL] [Abstract][Full Text] [Related]
3. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
4. Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.
Roth T; Wright KP; Walsh J
Sleep; 2006 Mar; 29(3):335-41. PubMed ID: 16553019
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
6. Dose-response effects of tiagabine on the sleep of older adults.
Walsh JK; Randazzo AC; Frankowski S; Shannon K; Schweitzer PK; Roth T
Sleep; 2005 Jun; 28(6):673-6. PubMed ID: 16477953
[TBL] [Abstract][Full Text] [Related]
7. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
9. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
Rosenberg R; Caron J; Roth T; Amato D
Sleep Med; 2005 Jan; 6(1):15-22. PubMed ID: 15680290
[TBL] [Abstract][Full Text] [Related]
11. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
Pollack MH; Tiller J; Xie F; Trivedi MH
J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
[TBL] [Abstract][Full Text] [Related]
12. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
13. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of indiplon in older adults with primary insomnia.
Walsh JK; Moscovitch A; Burke J; Farber R; Roth T
Sleep Med; 2007 Nov; 8(7-8):753-9. PubMed ID: 17825616
[TBL] [Abstract][Full Text] [Related]
16. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
Erman M; Seiden D; Zammit G; Sainati S; Zhang J
Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
18. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
19. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
Davidson JR; Brady K; Mellman TA; Stein MB; Pollack MH
J Clin Psychopharmacol; 2007 Feb; 27(1):85-8. PubMed ID: 17224720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
